Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies.

Subjects

Subjects :

Camptothecin adverse effects
Camptothecin therapeutic use
Camptothecin toxicity
Cystitis chemically induced
Humans
Leukocyte Count
Leukopenia chemically induced
Neoplasms blood
Neoplasms drug therapy
Thrombocytopenia chemically induced
Camptothecin administration & dosage

Details

Language :

English

ISSN :

0069-0112

Volume :

56

Issue :

4

Database :

MEDLINE

Journal :

Cancer chemotherapy reports

Publication Type :

Academic Journal

Accession number :

5081595